Literature DB >> 16251813

Hepatitis C virus populations in the plasma, peripheral blood mononuclear cells and cerebrospinal fluid of HIV/hepatitis C virus-co-infected patients.

Sabrina Bagaglio1, Paola Cinque, Sara Racca, Rosa Pedale, Maria Angela Grasso, Adriano Lazzarin, Giulia Morsica.   

Abstract

BACKGROUND: Chronic hepatitis C virus (HCV) infection has occasionally been associated with diseases of the central nervous system, thus suggesting that the virus has a direct effect on cerebral function.
OBJECTIVE: To investigate the presence and heterogeneity of HCV populations in the cerebrospinal fluid (CSF), plasma and peripheral blood mononuclear cells (PBMC) of HIV-infected and anti-HCV-positive patients.
METHODS: Reverse transcriptase-polymerase chain reaction was used to detect HCV RNA in 21 paired CSF/plasma samples and 20 PBMC samples from HIV/HCV-positive patients. HCV was genotyped by means of a hybridization assay, and its compartmental heterogeneity was analysed by cloning the related amplicons.
RESULTS: All of the plasma samples, 14 out of 20 PBMC samples and five out of 21 CSF samples were positive for HCV RNA. Of the five patients with HCV-positive CSF, two had the same genotype in the plasma/CSF/PBMC samples, two had a different genotype in the CSF from that in plasma and PBMC, and one had the same genotype in paired CSF/plasma samples. An analysis of the HCV populations showed that two patients seemingly infected with the same genotype in different compartments harbored mixed infection in the CSF but not in the plasma and PBMC samples.
CONCLUSIONS: These findings of different HCV genetic diversification in different compartments suggest that CSF is an independent site of viral replication and persistence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251813     DOI: 10.1097/01.aids.0000192085.87302.39

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

2.  Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.

Authors:  Marcia D McNutt; Shuling Liu; Amita Manatunga; Erica B Royster; Charles L Raison; Bobbi J Woolwine; Marina F Demetrashvili; Andrew H Miller; Dominique L Musselman
Journal:  Neuropsychopharmacology       Date:  2012-02-22       Impact factor: 7.853

3.  Analysis of the 5'UTR of HCV genotype 3 grown in vitro in human B cells, T cells, and macrophages.

Authors:  Dennis Revie; Michael O Alberti; John G Prichard; Ann S Kelley; S Zaki Salahuddin
Journal:  Virol J       Date:  2010-07-13       Impact factor: 4.099

4.  Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients.

Authors:  D B Clifford; M Smurzynski; L S Park; T-M Yeh; Y Zhao; L Blair; M Arens; S R Evans
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

5.  Clinicopathologic correlates of hepatitis C virus in brain: a pilot study.

Authors:  Jacinta Murray; Sarah L Fishman; Elizabeth Ryan; Francis J Eng; José L Walewski; Andrea D Branch; Susan Morgello
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

Review 6.  Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging features.

Authors:  Eileen M Martin-Thormeyer; Robert H Paul
Journal:  Neuropsychol Rev       Date:  2009-05-27       Impact factor: 7.444

Review 7.  Detection of GB virus C genomic sequence in the cerebrospinal fluid of a HIV-infected patient in China: a case report and literature review.

Authors:  Z Liu; Y Zhang; F Wei; M Xu; D Mou; T Zhang; W Li; D Chen; H Wu
Journal:  Epidemiol Infect       Date:  2015-06-17       Impact factor: 4.434

Review 8.  Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  Virol J       Date:  2011-07-11       Impact factor: 4.099

9.  Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin.

Authors:  Sabrina Bagaglio; Caterina Uberti-Foppa; Clelia Di Serio; Filippo Trentini; Andrea Andolina; Hamid Hasson; Emanuela Messina; Marco Merli; Lucy Porrino; Adriano Lazzarin; Giulia Morsica
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.